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Summary
Background: There is a high burden of morbidity due to neglected tropical diseases.
To help address this, the World Health Organization recommends integration of case
management (CM). Here, we present a practical framework designed to identify areas
that could benefit from an integrated CM strategy in Ghana. We also investigated the
accessibility of primary health care (PHC) to CM cases, and the impact of this on
morbidity at diagnosis.
Methods: Routinely detected cases of Buruli ulcer (BU) and leprosy, and suspected
lymphedema identified through morbidity surveys during mass drug administration
campaigns in Ghana in 2014 were remotely georeferenced. We estimated distances
from cases’ home communities to the nearest primary healthcare facility (PHC), and
compared rates of reported disease, completeness of clinical information, and risk of
more severe morbidity, relative to PHC accessibility.
Results: We georeferenced communities of 295/350 reported leprosy cases,
240/333 BU cases, and 1,557/2383 instances of lymphedema. Overlap of these
diseases was predominantly around Accra and in the Upper East Region. Rates of
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reported disease appeared higher in populations with higher accessibility to PHC, and
leprosy cases living further from PHC had a higher risk of disability at diagnosis.
Conclusions: This investigation demonstrates the feasibility and value of using
routinely collected data to map CM-NTDs at low cost. The maps presented are
intended to provide a resource for planning the implementation of integrated CM for
NTDs in Ghana. This approach could be easily implemented by national health
services in other endemic countries in the future.
Introduction
Several neglected tropical diseases (NTDs) are characterised by chronic infections associated
with long-term morbidity.1 These diseases have a considerable impact on public health as a
result of their debilitating and stigmatising symptoms and sequelae, which can lead to
permanent disfigurement and disability.2 The burden of disease due to NTDs falls almost
exclusively on poor communities in Africa, Asia and South America.3
The NTDs are often categorised by their main control strategy: the preventive
chemotherapy (PC) NTDs are amenable to control through mass drug administration (MDA),
whereas the intensified case management (ICM) NTDs require an individual-level approach
involving early diagnosis and treatment of the infection to reduce morbidity, and the
management of complications.4 While MDA has reduced transmission of the PC-NTDs, the
burden of morbidity due to NTDs remains high. Infections including Buruli ulcer (BU),
leprosy, lymphatic filariasis (LF), onchocerciasis, trachoma and yaws can result in permanent
disfigurement and disability, with patients requiring ongoing treatment for prevention or
alleviation of morbidity (hereafter referred to as case management, CM). There is substantial
overlap in the strategies for CM for different NTDs. For example, trachoma and leprosy can
cause damage to the eye, resulting in vision impairment which can progress to blindness
without appropriate clinical management.5,6 Surgery is required to repair hydrocele resulting
from LF and to treat severe cases of BU7 and complications due to leprosy.8,9 Physiotherapy
can improve cases where mobility is compromised due to lymphedema, BU or leprosy.10 – 12
Other common components of CM for these diseases include hygiene, skin care and wound
care, which can be delivered by the patient themselves or by a care-giver, following
appropriate health education.12
Due to the overlap in several aspects of CM, the World Health Organisation (WHO) has
recommended the integration of CM interventions, to achieve a more cost-effective use of
resources.12 – 15 Integration of CM interventions could be implemented through integrated pre-
and in-service training of health workers, the delivery of supplies such as footwear, hygiene
products and medicines, integrated monitoring and integrated self-care groups in communities
that are co-endemic for these diseases.12 An additional and related aspect of integration is the
inclusion of NTD services with general health services, necessary to accompany a move away
from vertical programme structures as programmes integrate their activities.
Planning the integration of CM activities requires information on the distribution and
burden of NTD-related morbidity, so that resources and activities can be targeted to where
disease burdens are highest, and integrated where they overlap. The availability of precise
and accurate data on NTD-related morbidity is extremely limited, but prevalence surveys to
generate this information are often prohibitively expensive. Existing data sources include
health facility case registers and morbidity surveys carried out in the context of MDA for
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diseases such as LF and onchocerciasis. While it is recognised that these routine data sources
do not provide a complete representation of the burden and distribution of disease, they do
indicate the burden of cases already visible to the health system, which may provide a useful
resource for the initial phase of integration of CM activities.
As a process within the health system, the integration of CM within NTD programmes
would be informed by overlap of disease at the level at which CM activities are managed and
coordinated, namely the district level in Ghana. Meanwhile, integration of CM at the point of
delivery would be based upon overlap of disease at the level of local health facilities, where
patients access basic care. Healthcare delivery structures play a key role in passive
surveillance, representing the entry point of patients into the surveillance system as well as
the health system. In the context of routine surveillance, the accessibility of services for
diagnosis and treatment of NTDs is an essential consideration in planning the integration of
CM, and in evaluating the quality of passive surveillance data for this purpose. Previous work
has demonstrated that rates of health facility attendance are strongly influenced by the
distance patients have to travel to access these facilities.16 The accessibility of health
facilities to populations at risk for NTDs may therefore be expected to impact reporting rates
and diagnostic delay, and consequently influence key epidemiological indicators such as rates
of reported disease and of more severe morbidity at diagnosis.
In this investigation, we mapped the distributions of routinely reported cases of leprosy,
BU, and lymphedema presumably related to LF detected in Ghana in 2014, alongside the
locations of health facilities expected to diagnose and treat these conditions. We aimed to
investigate rates of reported disease, the completeness of key clinical data, and the risk of
more severe morbidity at diagnosis, relative to the accessibility of PHC health facilities. In
addition, we integrated data sources to identify co-occurrence of CM-NTD cases at district
level, and co-occurrence of morbidity resulting from these diseases at health facility level.
The broader goal of this analysis was to assess the potential for integration of CM activities,
particularly wound management and prevention of disability for patients with leprosy, BU,
and lymphedema.
Methods
STUDY DESIGN, SETTING AND DATA SOURCES
This study was a retrospective cross-sectional study of the distributions of BU, leprosy and
LF-related lymphedema in the Republic of Ghana: a country with a population of
approximately 28 million and a total land area of 238,537 km2.17 It lies on the southern coast
of West Africa, bordered by Coˆte d’Ivoire to the west, Burkina Faso to the north and Togo to
the east. The country is divided into 10 administrative regions, which are further divided into
216 districts (Figure 1).
The average population of a district is just over 100,000 people.
Primary health care (PHC) facilities in Ghana include Community-Based Health Planning
and Services (CHPS), providing basic essential health services at community level, and
health centres at sub-district level.18 CHPS compounds are intended to service a maximum of
5,000 people, or 1–3 communities.19,20 Health centres are intended to serve up to 25,000
people.19
The disease data mapped in this investigation was collected by the Leprosy Elimination
Programme (LEP), the National Buruli Ulcer Control Programme (NBUCP) and the NTD
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programme in Ghana, as part of their routine surveillance and control activities in 2014.
Reflecting the structural organisation of NTD control in Ghana, which consists of separate
control programmes for each disease, the methods of primary and secondary data collection
varied between datasets for the different diseases.
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Figure 1. Density distribution of reported leprosy cases in Ghana in 2014 and the locations of the recorded reporting
health facilities (HF).
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The Ghana LEP does not undertake active case searches, but implements community
health education activities to train volunteers to suspect and refer cases. These activities were
implemented in all regions in 2014. Patients who present passively or who are referred by a
community volunteer (CV) or health worker (HW) are sent to a health centre or district
hospital for diagnosis. Clinicians grade patients according to the WHO leprosy disability
grading system21 and record this information in hospital records. The home address of
patients is recorded for case-holding purposes. Data is aggregated to regional level by district
programme officers, and reported monthly to the national level. To obtain information on the
home residence of cases diagnosed in 2014, all regional officers from the LEP were contacted
by telephone, and provided with a standardised electronic form (Microsoft Excel 2010:
Microsoft Corporation, Redmond, WA) in which to record the cases from their respective
regions. The electronic forms included the district and community of each case, the health
facility where treatment was given and the disability grade at diagnosis. All leprosy cases
were considered to require CM and so were shown on the integrated morbidity map. The data
was validated by comparison of district totals to a district level-aggregated dataset compiled
separately by the LEP from routine reports from the regions.
A line-list of all BU cases reported nationally in 2014 was provided by the NBUCP. The
NBUCP collects data through passive surveillance from health facilities, and conducts active
case searches in known disease foci. In 2014, active case searches were implemented in
Ashanti and Brong Ahafo Regions. Cases detected through active case search were not
distinguished from those passively reported in the surveillance line-list, although the referral
source (self/community volunteer (CV)/health worker (HW)/former patient/other) was
recorded. Cases referred by CVs or HWs would include all cases detected through active
surveillance, so the proportion diagnosed through these routes may indicate the relative
contribution of active case searches. For each case reported, we extracted data on the place of
residence (community, district and region name); clinical information including limitation of
movement (LOM) at diagnosis, the category and type of lesion;22 laboratory confirmation by
Ziehl Neelsen (ZN) staining and/or polymerase chain reaction (PCR); the referral source; and
if available, the health facility where treatment started. We did not restrict the investigation to
confirmed cases because a substantial proportion had no laboratory test result recorded. Cases
were excluded if they were negative by PCR or negative by ZN if PCR diagnosis was not
available. To investigate the possible impact of active surveillance activities on case
detection rates, we compared the performance of Ashanti and Brong Ahafo Regions to the
country overall in terms of WHO targets for early case detection.23 Cases with either LOM at
diagnosis or category II or III lesions were considered most likely to require ongoing CM and
mapped on the integrated morbidity map.
Regarding LF-related lymphedema, the NTD programme provided reporting sheets from
the MDA campaigns for LF and onchocerciasis, conducted between June and August 2014.
These datasets include morbidity registration data collected by community drug distributors
(CDDs) during drug administration. The MDAs were conducted in a total of 141 endemic
districts in all regions apart from the Volta Region, which is non-endemic for LF and
onchocerciasis, and does not implement morbidity registration for hydrocele and
lymphedema. From these reports, we extracted information on the number of suspected
cases of lymphedema recorded in each community that had received MDA. The cases
recorded are not clinically confirmed, and are only identified based on questioning and visual
evidence of lower limb swelling. All suspected lymphedema cases were displayed on the
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integrated map; hydrocele cases were not mapped because the main intervention for this
condition is surgery, rather than ongoing management and disability prevention.
GEO-REFERENCING CASE REPORT DATA
For community-level disease mapping, we aimed to georeference all communities that
reported cases of leprosy, BU, or suspected lymphedema. A range of tools was used to find
coordinates, including Bing Maps,24 Google Maps,25 the Fuzzy Gazetteer26 and the
OpenStreetMap Project.27 Other sources were used to estimate the geographical positions of
communities that were not found using online search tools. These sources included the
Geographic Names Database of the National Geospatial-Intelligence Agency,28 maps
published by the Ghana Statistical Service,29 the Ghana National Development and Poverty
Commission,30 the Local Governance and Decentralization Program,31 and the Millennium
Development Authority.32 Paper maps were obtained from the Headquarters of the Survey
Department of the Lands Commission in Accra, Ghana. A list of settlements that could not be
georeferenced was recorded.
The geo-referenced data was assembled within a geographic information system in
QGIS,33 along with the georeferenced health facilities, and other datasets including national
boundary, inland water34 and population density data.35 We obtained a list of georeferenced
health facilities in Ghana.36 We used the QGIS Heatmap plugin37 to map density distributions
for leprosy, BU and suspected lymphedema via non-parametric Kernel Density Estimation
(KDE), using a Gaussian function and a search radius of 10 km.
ESTIMATING THE ACCESSIBILITY OF PRIMARY HEALTH SERVICES
PHC facilities (including CHPS compounds, clinics and health centres in the health facility
dataset) were assumed to be the first point of contact with the health system for leprosy and
BU cases, which were largely recorded through passive case detection. We used Euclidean
(straight-line) distance as indicator of the accessibility of these health facilities. The estimate
of Euclidean distance was considered more appropriate than Manhattan distance (through a
road network) for measuring distance in this context because it was assumed that journeys to
local health facilities were most likely to be made on foot, so may not be well-represented by
the mapped road network. This assumption is supported by evidence from household surveys
and focus group discussions conducted as part of a study in a rural district of the Upper West
Region of Ghana, which revealed walking to be the most common means of transport to
CHPS compounds and HCs.18
We measured the distance of each mapped case of leprosy, BU and suspected
lymphedema to the nearest PHC facility. We defined zones of good accessibility to PHC
facilities across the whole country using buffers of radius 5 km around PHC facilities. This
follows the approach of Agbenyo et al.18 in categorising the accessibility of CHPS
compounds. In each region, the population within 5 km of a PHC facility was estimated by
summing pixel values of population per grid square (from a raster dataset obtained from
the WorldPop project35) within dissolved buffer zones. These values were subtracted from
regional population totals to estimate the population beyond 5 km of a PHC in each
region.
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ESTIMATING THE RATE OF REPORTED CASES AND THE RISK OF MORBIDITY BY
DISTANCE TO PHC FACILITY
We estimated reported rates and proportions of leprosy, BU and suspected lymphedema in
population zones within and beyond 5 km of a PHC facility at national and regional levels,
and calculated rate ratios (RR) of cases in populations within and beyond 5 km of a PHC
facility, using the calculated population estimates as denominators. We conducted a
sensitivity analysis on the estimated rate ratios by calculating maximum possible rates within
and beyond 5 km of a PHC facility assuming all non-georeferenced cases were more than
5 km from a health facility (to calculate the lower boundary for RR) or within 5 km (to
calculate the upper boundary). As indicators of more severe morbidity at diagnosis, we
calculated the proportion of leprosy cases with G1/2D at diagnosis, and the proportion of BU
cases with category II or III lesions or LOM at diagnosis.
IDENTIFYING OVERLAP OF NTD MORBIDITY IN LOCAL HEALTH FACILITIES
Potential treatment facilities were those considered likely to be able to deliver basic case
management for patients with leprosy, BU or lymphedema. We included facilities
categorised as clinic; health centre; district hospital; hospital; metropolitan hospital;
municipal hospital; polyclinic; regional hospital or training institution in this group. We
linked all mapped cases of leprosy and lymphedema, and mapped cases of BU with Category
II-III lesions or LOM at diagnosis to their nearest health facility, measured by Euclidean
distance. We identified health facilities that were linked to at least two cases of morbidity
attributable to different diseases (BU, LF or leprosy). This co-distribution was represented
using proportional pie chart maps showing the total number of morbidity cases linked to each
facility, and the proportion of cases caused by each of the three diseases.
ETHICS STATEMENT
Permission to conduct this work was granted by the Ghana Health Service Ethical Review
Committee and the London School of Hygiene and Tropical Medicine MSc Research Ethics
Committee (reference number 9798). Patient informed consent was not required because no
patient-identifiable information was stored. Data were aggregated to community-level for
analysis and presentation, so there was no possibility of identification of individuals.
Results
DISTRIBUTION OF REPORTED LEPROSY, BU, AND SUSPECTED FILARIAL
LYMPHEDEMA
In total, 351 new cases of leprosy were reported from 306 communities in 94 districts, with
cases recorded from all regions. One case reported from the Upper East Region was excluded
as the case was not a resident of Ghana. The separate dataset compiled by the LEP included
317 cases in 84 districts. Precise data on new cases detected from 24 districts in 2014 was not
available to the LEP; of these, four were reported by the regional programme officers to have
recorded cases in 2014, with a combined total of 29 cases. Of the 192 districts with reporting
data verified by the LEP, the number of cases reported was the same as the number extracted
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from the district and hospital records in 123 districts (64·1%). In 43 districts, there was a
discrepancy of one to two cases, while three districts showed a discrepancy of more than five
cases between the datasets (Figure 1S in supplementary file).
Overall, 195 leprosy cases (55·7%) had no disability, 34 (9·7%) had G1D and 35 (10·0%)
had G2D at diagnosis. Data on disability grade was missing for 86 cases (24·4%). Fifty-five of
the cases (15·7%) were not georeferenced. The clinic was recorded for 310 cases, but was
missing from all cases in the Western Region (Figure 1). The distribution of georeferenced
leprosy cases, including those whose clinic was recorded and georeferenced (n ¼ 216) and
those whose clinic was not known or not georeferenced (n ¼ 79), is shown on the density map
in Figure 1, along with the locations of the reporting facilities. Mapped cases were sparse in
the Northern and Eastern Regions, but these regions had high proportions of cases that were
not georeferenced.
A total of 409 new clinical diagnoses of BU were reported from 254 communities in six
regions (Ashanti, Brong Ahafo, Central, Eastern, Greater Accra and Western). A high
proportion of the cases in Ashanti were referred by CVs and HWs, suggesting that active case
searches made a greater contribution to case detection in this region than in Brong Ahafo
Region, where a lower proportion was referred by health professionals. Table 1S (in
supplementary file) shows referral routes and performance against WHO indicators for early
diagnosis by region.
Samples from 321 patients (78·5%) had been tested for M. ulcerans using PCR, of these
250 (77·9%) had tested positive and 71 (22·1%) were negative. Of the 88 patients not
analysed by PCR, 7 had been tested for the presence of mycobacteria using ZN staining; two
were positive and five were negative. In total, 333 patients were positive or untested for
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Figure 2. Density distribution of BU cases reported in Ghana in 2014 and the locations of the recorded reporting
health facilities (HF).
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M. ulcerans but considered suspicious of BU; these are hereafter referred to as ‘cases’. Two
hundred and fourteen cases (64·3%) had either category II or III lesions or LOM at diagnosis.
Fifty-three cases (15·6%) were not georeferenced. Health facility was recorded for 137/333
BU cases (41·1%). Thirty-three out of 43 recorded health facilities (76·7%) were
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NORTHERN
UPPER EAST
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Density of cases
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Figure 3. Density distribution of suspect cases of filarial lymphedema detected in morbidity surveys for mass drug
administration campaigns (MDA) in Ghana in 2014.
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georeferenced. The distribution of georeferenced BU cases, including those whose clinic was
recorded and georeferenced (n ¼ 82), and those for which reporting clinic was unknown or not
georeferenced (198), is shown on the density map in Figure 2, along with the reporting
facilities.
Morbidity registration conducted through LF and onchocerciasis community-based MDA
identified 2,383 suspect cases of lymphedema in 1,043 communities. The communities of 826
individuals (34·7%) could not be georeferenced. Cases were heavily concentrated in the Upper
East Region, and the distribution was scattered throughout the rest of the country (Figure 3).
The density of mapped cases was low in the Northern and Brong Ahafo regions, and
increased towards the south of the country. There were some pockets of high concentration
along the coast. The proportion of communities that were georeferenced was lowest in the
Upper East, Northern and Brong Ahafo Regions, and highest in the southern regions.
ACCESSIBILITY OF PHC FACILITIES
Seventy-five percent of the overall population was within 5 km of a PHC facility. This
proportion varied between regions (Table 1).
At national level, rates of reported and georeferenced leprosy, BU and suspect filarial
lymphedema were higher in the population within 5 km of a PHC facility. All regions had
higher rates of reported and georeferenced leprosy and most had higher rates of reported and
georeferenced BU in the population within 5 km of a PHC facility. This pattern was not
observed for filarial lymphedema: four out of eight regions that reported data- including the
two regions with the lowest access to PHC facilities- had lower rates of recorded cases in the
population within 5 km of a PHC facility (Table 1). The relationship between the rate of
reported cases and the accessibility of PHC was sensitive to the location of the non-
georeferenced cases: when these were assumed to occur beyond 5 km of a PHC facility
(rather than excluded), rates of leprosy and BU at national level and in most regions were
higher in populations beyond 5 km of PHC (Table 2S, supplementary file).
Regardless of the assumed location of non-georeferenced cases, the rate of reported
leprosy was higher in the population within 5 km of a PHCF in the Volta and Upper West
Regions, and the rate of reported BU was higher within 5 km of a PHCF in the Eastern and
Brong Ahafo Regions (Table 2S, supplementary file).
Georeferenced leprosy cases occurring more than 5 km from a PHC facility were less
likely to have been graded at diagnosis than those living within 5 km of a PHC facility (Table
3S, supplementary file).
Among graded cases, the proportion with G1/2D was higher in those living further away
from a PHC facility (Table 2).
The completeness of clinical indicators for BU cases was high, both in cases located
within and beyond 5 km of a PHC facility (Table 3S, supplementary file). The proportion of
BU cases with LOM or category II-III lesions was similar in populations within and beyond
5 km of a PHC facility, but was higher in non-georeferenced cases (Table 2).
OPPORTUNITIES FOR INTEGRATED CM
Overlap of morbidity due to leprosy and lymphedema occurred in all regions apart from the
Volta Region, where LF-related morbidity was not recorded, and the Upper West, from which
reporting sheets were not available. In the Upper East Region, there were high case numbers
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Table 1. Regional rates of reported leprosy, Buruli ulcer (BU) and suspected filarial lymphedema, within and beyond
5 km of a primary healthcare (PHC) facility in Ghana in 2014
Area %1
Reported leprosy cases
<5 km from PHC >5 km from PHC
Rate Ratio4N Rate (95% CIs) N Rate (95% CIs)
All Regions 75·4 251 1·3 (1·1–1·4) 44 0·7 (0·5–0·9) 1·86
Greater Accra 95·5 28 0·7 (0·5–1) 0 0 (0–1·9) –
Upper East 93·0 31 3 (2–4·2) 2 2·6 (0·3–9·3) 1·17
Ashanti 83·7 34 0·8 (0·5–1·1) 3 0·4 (0·1–1) 2·20
Central 74·5 6 0·3 (0·1–0·7) 2 0·3 (0–1·2) 1·03
Volta 74·5 46 2·7 (2–3·6) 3 0·5 (0·1–1·5) 5·24
Western 70·0 22 1·2 (0·8–1·9) 7 0·9 (0·4–1·9) 1·35
Eastern 68·7 24 1·2 (0·8–1·8) 0 0 (0–0·4) –
Brong Ahafo 61·6 25 1·6 (1·1–2·4) 10 1 (0·5–1·9) 1·56
Upper West 58·3 23 5·3 (3·3–7·9) 7 2·3 (0·9–4·6) 2·35
Northern 51·1 12 0·9 (0·5–1·5) 10 0·8 (0·4–1·4) 1·15
Area %1
Reported BU cases
< 5 km from PHC > 5 km from PHC
Rate Ratio4N Rate (95% CIs) N Rate (95% CIs)
All Regions 75·4 246 1·2 (1·1–1·4) 34 0·5 (0·4–0·7) 2·36
Greater Accra 95·5 30 0·7 (0·5–1) 1 0·5 (0–2·9) 1·42
Ashanti 83·7 94 2·2 (1·8–2·7) 17 2 (1·2–3·3) 1·07
Central 74·5 25 1·4 (0·9–2·1) 9 1·5 (0·7–2·8) 0·95
Western 70·0 12 0·7 (0·3–1·2) 3 0·4 (0·1–1·1) 1·71
Eastern 68·7 56 2·9 (2·2–3·7) 1 0·1 (0–0·6) 25·53
Brong Ahafo 61·6 29 1·9 (1·3–2·7) 3 0·3 (0·1–0·9) 6·03
Area %2
Reported cases of suspected filarial lymphedema
< 5 km from PHC > 5 km from PHC
Rate Ratio4N Rate3 (95% CIs) N Rate3 (95% CIs)
All Regions 72·8 1296 10·2 (9·7–10·8) 261 4·9 (4·3–5·5) 2·09
Greater Accra 99·2 25 0·9 (0·6–1·3) 0 0 (0–2·5) –
Upper East 93·0 948 91·4 (85·7–97·4) 62 80·2 (61·5–102·9) 1·14
Ashanti 71·8 8 0·4 (0·2–0·8) 7 0·9 (0·3–1·8) 0·49
Central 71·2 103 7·6 (6·2–9·2) 20 3·2 (2–5) 2·34
Western 70·0 117 6·5 (5·4–7·8) 61 7·9 (6–10·1) 0·83
Eastern 67·8 43 3·1 (2·2–4·1) 19 2·3 (1·4–3·6) 1·33
Brong Ahafo 56·8 12 1·2 (0·6–2·2) 27 3·1 (2–4·5) 0·40
Northern 52·5 40 3·1 (2·2–4·2) 65 5·4 (4·2–6·9) 0·57
1Proportion of population living within 5 km of a primary health facility (PHF).
2Proportion of population within 5 km of a PHF, in districts where LF morbidity registration was implemented in
2014.
3Rates of leprosy and BU were calculated from the number of newly reported cases in 2014 per 100,000
population; rates of suspected lymphedema were calculated from the number of suspect cases recorded during
morbidity registration, per 100,000 population.
4Ratio of the rate within 5 km of PHC to that beyond 5 km of PHC.
Regional populations, populations in districts where morbidity registration was implemented, and populations
within 5 km of a PHC facility were estimated using data from the WorldPop project (1).
CIs ¼ confidence intervals, calculated using Byar’s method.
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Table 2. Numbers and proportions of leprosy cases with grade 1/2 disability at diagnosis, and Buruli Ulcer (BU) cases with category II/III lesions or limitation of movement
(LOM) at diagnosis, by distance to nearest primary health care facility in georeferenced cases, and in non-georeferenced cases. Data are from Ghana in 2014 and are shown by
region
All Regions
Reported leprosy cases
<5 km >5 km Total Mapped Total not georeferenced
N. graded With G1/2D N. graded With G1/2D N. graded With G1/2D N. graded With G1/2D
N % (95% CIs) N % (95% CIs) N % (95% CIs) N % (95% CIs)
208 53 25·5 (20–31·8) 27 9 33·3 (18·6–52·2) 235 62 26·4 (21·2–32·4) 29 7 24·1 (12·2–42·1)
Ashanti 34 14 41·2 (26·4–57·8) 3 3 100 (43·9–100) 37 17 45·9 (31–61·6) 9 3 33·3 (12·1–64·6)
Brong Ahafo 25 9 36 (20·2–55·5) 10 3 30 (10·8–60·3) 35 12 34·3 (20·8–50·8) 7 3 42·9 (15·8–75)
Central 6 1 16·7 (3–56·4) 2 0 0 (0–65·8) 8 1 12·5 (2·2–47·1) 1 1 100 (20·7–100)
Eastern 13 7 53·8 (29·1–76·8) 0 0 0 13 7 53·8 (29·1–76·8) 1 0 0 (0–79·3)
Greater Accra 28 11 39·3 (23·6–57·6) 0 0 0 28 11 39·3 (23·6–57·6) 0 0 0
Northern 2 2 100 (34·2–100) 0 0 0 2 2 100 (34·2–100) 0 0 0
Upper East 31 2 6·5 (1·8–20·7) 2 0 0 (0–65·8) 33 2 6·1 (1·7–19·6) 2 0 0 (0–65·8)
Upper West 23 6 26·1 (12·5–46·5) 7 3 42·9 (15·8–75) 30 9 30 (16·7–47·9) 7 0 0 (0–35·4)
Volta 46 1 2·2 (0·4–11·3) 3 0 0 (0–56·1) 49 1 2 (0·4–10·7) 2 0 0 (0–65·8)
Western 0 0 0 0 0 0 0 0 0 0 0 0
All Regions
Reported BU cases
< 5 km > 5 km Total Mapped Total not georeferenced
N. graded With cat II-III or LOM N. graded With cat II-III or LOM N. graded With cat II-III or LOM N. graded With cat II-III or LOM
N % (95% CIs) N % (95% CIs) N % (95% CIs) N % (95% CIs)
216 156 72·2 (65·9–77·8) 29 20 69 (50·8–82·7) 245 55 67·9 (57·1–77·1) 53 42 84 (71·5–91·7)
Ashanti 69 47 68·1 (56·4–77·9) 12 8 66·7 (39·1–86·2) 81 22 81·5 (63·3–91·8) 25 16 72·7 (51·8–86·8)
Brong Ahafo 24 20 83·3 (64·1–93·3) 3 2 66·7 (20·8–93·9) 27 26 76·5 (60–87·6) 0 0 0
Central 25 19 76 (56·6–88·5) 9 7 77·8 (45·3–93·7) 34 36 63·2 (50·2–74·5) 5 4 80 (37·6–96·4)
Eastern 56 36 64·3 (51·2–75·5) 1 0 0 (0–79·3) 57 22 71 (53·4–83·9) 5 5 100 (56·6–100)
Greater Accra 30 22 73·3 (55·6–85·8) 1 0 0 (0–79·3) 31 15 100 (79·6–100) 10 10 100 (72·2–100)
Western 12 12 100 (75·8–100) 3 3 100 (43·9–100) 15 0 0 (0–0) 8 7 87·5 (52·9–97·8)
1out of those with DG recorded. 2out of cases with at least one of these indicators available.
CIs ¼ confidence intervals, calculated using the Wilson Score method.
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of lymphedema and leprosy, and extensive overlap between these two causes of morbidity. In
parts of Greater Accra and across the northern border into the Eastern Region, there was
overlap of morbidity due to BU, leprosy, and lymphedema (Figure 4).
At district-level, overlap of these conditions was relatively common: 42 of 216 districts
reported at least two of BU, leprosy and lymphedema (Table 3).
Discussion
The maps presented in this work show the burden of BU, leprosy and filarial lymphedema that
is already visible to the health system in Ghana. We have used the mapped data to identify
0 10 20 30 40
0 0 10 20 30 40 km
km
HFs with overlap of morbidity
Buruli Ulcer
Leprosy
Lymphedema
District MDA coverage
No MDA
50 100 km150 200
Figure 4. Overlapping morbidity caused by leprosy, BU and lymphedema in health facilities Ghana, in the Upper
East Region, and in and around Accra.
Table 3. The number of districts in Ghana reporting routinely detected cases of lymphedema, leprosy and Buruli
ulcer (BU) in 2014
Number of conditions recorded (BU, leprosy, lymphedema) Number of districts %
0 52 24·1
1 122 56·5
2 39 18·1
3 3 1·4
Total 216
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overlap of CM-disease within existing health care facilities that would deliver care for
patients. NTD-related morbidity was primarily identified in areas where the population had a
greater level of geographical access to primary healthcare. The accessibility of PHC facilities
may impact the rate of recorded cases, although specific reasons for this are not clear and
multiple factors are likely to be involved. Lower accessibility of PHC facilities was related to
a higher risk of more advanced morbidity for leprosy, but not for BU. These results could help
to inform the implementation of integrated morbidity management, in line with WHO
recommendations for NTD control.
The use of routine data was a key aspect of this investigation, and we recognise that these
data sources entail certain limitations, especially around under-detection and under-reporting
of cases. There were some discrepancies between the numbers of leprosy cases collated by
the regional programme officers from hospital and district registers, and the numbers reported
by the regional programme officers to the LEP. The main cause of the discrepancy in the
national totals is likely to be that four districts in which cases had been recorded did not report
data to the NLP. The main cause of discrepancies in the totals at district-level is different
allocation of cases to districts within this exercise and by the LEP. Within this exercise, cases
were allocated to district of residence, while the LEP allocates cases to the district of the
facility in which they were diagnosed.
Leprosy and BU are recognised to be under-reported globally,38,39 with evidence of
under-diagnosis and under-reporting in passive case detection systems in a range of
settings.40 – 42 It is also important to note that the data on LF was collected by volunteers, and
is not clinically verified; a proportion of the recorded lymphedema cases included here may
not be caused by LF. Validation studies would be required to assess the impact of this on our
results. Meanwhile, we expect that the data used in this investigation gives an underestimate
of the burden of filarial lymphedema: morbidity surveys conducted in the context of MDA
campaigns are demonstrated to detect fewer cases than dedicated surveys,43 and furthermore,
cases in districts that did not implement MDA for LF in 2014 would not be detected in this
system.
The impact of under-detection by passive surveillance is potentially more extreme in
communities with a lower level of access to PHC, which could introduce bias due to spatial
differences in availability and accessibility of health facilities to the population. We sought to
assess this by mapping the distribution of reported cases alongside that of reporting health
facilities, and by comparing the rates of reported disease in populations with higher and lower
estimated access to health facilities. The disease distribution maps show that cases whose
reporting health facility was recorded were generally close to those facilities. We also found
that rates of recorded and mapped leprosy and BU were higher in the population within 5 km
of a PHC facility, which may reflect higher rates of case ascertainment in populations with
better access to PHC facilities. Another possibility is that cases may travel for diagnosis and
treatment, and the community recorded in the clinic is not the case’s permanent place of
residence, but a temporary address where they are staying while under treatment. An
increased rate in populations closer to PHC facilities was also observed for suspected cases of
filarial lymphedema. The detection of this condition was not expected to be affected by the
accessibility of health services, as the MDA campaigns through which the cases were
recorded are supposed to be implemented homogeneously and massively across endemic
areas. An alternative explanation is that the apparent concentration of lymphedema cases
closer to PHC facilities is due to spatial differences in the availability of coordinates for
remote georeferencing: cases in larger towns are presumably more likely to be georeferenced,
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and more likely to be near a health facility, compared to those in smaller communities. This
would apply to the other morbidity conditions as well.
We undertook a sensitivity analysis to further explore the association between the rates of
detected NTD cases and the proximity of PHC facilities (results in Table 2S in supplementary
file).
In most regions, the calculated rate ratios of BU and leprosy cases within and beyond
5 km of the nearest health facility were sensitive to assumptions about the distribution of non-
georeferenced cases. Of the estimated upper and lower limits for the rate ratios, we expect the
latter (in which all non-georeferenced cases were assumed to occur .5 km from the nearest
PHC facility) to be more realistic, since non-georeferenced communities are probably small
and remote, and therefore less likely to be well served by PHC. Regardless of where non-
georeferenced cases were assumed to occur, calculated rates of reported leprosy were higher
in populations within 5 km of PHC in the Upper West and Volta Regions. Rates of reported
BU were higher in populations within 5 km of PHC in the Eastern and Brong Ahafo Regions,
regardless of the assumed location of non-georeferenced BU cases. These four regions all had
low or moderate levels of accessibility of PHC, implying more robust evidence for an effect
of PHC accessibility on the rate of reported disease in regions lacking good access to PHC.
When it was assumed that all cases of suspect filarial lymphedema occurred.5 km from the
nearest PHC facility, all regions had a higher rate in this population. This implies that the
entire effect of accessibility of PHC facilities on the rate of this condition may be explained
by varying availability of geo-data.
Leprosy cases that occurred more than 5 km from PHC facilities or were not
georeferenced were less likely to have been graded at diagnosis than cases located within
5 km of PHC facilities. This may be due to variation in data completeness between regions:
most regions had no missing clinical data whereas three regions had significant numbers
whose disability grading was unknown. This suggests a potentially high burden of
undiagnosed or unreported morbidity among cases in these regions, which is an important
consideration in terms of targeting resources for case management. Missing clinical data on
BU cases occurred in only two regions, but with little variation between mapped and
unmapped cases, or between cases within and beyond 5 km of primary healthcare facilities.
Six regions reported leprosy cases who were living further than 5 km from PHC facilities.
Overall, cases living further from PHC showed an increased risk of more advanced morbidity
at diagnosis (Table 2). This may reflect the impact of diagnostic delay on patients who have to
travel further to obtain health care.
Integration of the morbidity maps for leprosy, BU and lymphedema revealed co-
distribution of disease in all regions where at least two of the diseases had been reported. The
extent of overlap was most common in the Upper East and the Greater Accra Regions. These
regions had relatively high concentrations of both leprosy and lymphedema, and also had the
highest levels of access to primary healthcare facilities. The detected disease overlap may be
a result of higher rates of case detection in these areas. Forty-two instances of disease overlap
were identified at district level. These districts would be considered target areas for trialling
integration of NTD programme activities, including health worker training and coordination
of programme management.
Although routine surveillance data entails limitations, and is recognised to underestimate
true numbers of cases, the approach piloted here has many advantages that support its use in
mapping NTDs and their associated morbidity in the future. For autonomy and sustainability,
NTD programmes require access to internally and routinely generated data sources over
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which they have full ownership. This investigation demonstrates how such datasets can be
integrated and used to create a resource for the planning of interventions against NTD
morbidity. The datasets were readily available, and remote geo-referencing meant there was
no need for travel within country, implying a significant saving in monetary and time costs.
The process could be implemented by technical staff in NTD-endemic countries with some
support during the orientation of the protocol, and following basic GIS training. Overall,
these advantages mean that this approach to mapping could be developed into a sustainable
and routine component of NTD surveillance, implemented as part of national disease control
programmes.
Management of the mapping process by national programme officers would overcome
some of the limitations encountered in this pilot, in particular by reducing the impact of
missing data. Firstly, local knowledge would be used as a tool to locate communities that
could not be georeferenced using online or paper maps. Secondly, the use and feedback of
surveillance data in the form of morbidity and disease occurrence maps to the officers
responsible for reporting the data would likely lead to improvements in data collection,
management and reporting. Finally, updating the maps annually with newly reported
morbidity cases would provide a more complete representation of existing morbidity. The
accuracy and completeness of surveillance data could be further improved through the use of
modern electronic platforms such as smart phones for data collection and reporting (i.e. via
SMS and electronic forms).43 Overall, the method is likely to become more sensitive to detect
community-level overlap of morbidity over time.
In Ghana, the District Health Information Management System software DHIMS II,
developed and used by the GHS for reporting and analysing health data, would be an
appropriate platform for integrating datasets for mapping. Investment in improving the data
collection and reporting functions of this system would complement integrated data
collection activities, and avoid duplication in software development and maintenance, and in
training for data managers.
Achieving full population coverage of integrated CM services will require broader
development of NTD surveillance, strengthening of national control programmes, and of the
primary health care system.13,44 Integrated mapping of NTD morbidity, alongside the
primary healthcare system, is an essential first step in identifying population health needs, to
ensure that investment in these areas is appropriately directed. We recommend the use of
routine data sets in this undertaking, in order to promote in-country ownership and
management of all aspects of NTD control.
Conclusions
This study has identified substantial overlap of NTD-related morbidity in Ghana. There was
an apparent concentration of cases and morbidity overlap in areas which have higher levels of
access to primary health facilities, although it is not clear whether this is due to differences
in surveillance coverage, the availability of geo-data, or differences in disease distribution.
Validation surveys would clarify this issue. In Ghana, the maps presented here are already
supporting the development of a strategic plan for integrated case management of morbidity
associated with NTDs. As this plan is implemented, it will be critical to update these maps
with current data.
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The exercise piloted here is intended to represent the start of an iterative process to
provide detailed and up-to-date information to target integrated interventions against CM-
NTDs. As the approach develops, parallel improvements to data collection systems will be
vital to provide a more accurate and reliable representation of disease burden, in order to
inform targeting of resources and activities on a national scale. It is hoped that the
integration of data collection tools will lead to an overall improvement in surveillance
systems for NTDs.
NTD-related morbidity affects the lives and livelihoods of millions of people
worldwide, and cannot be tackled simply by interrupting transmission of NTDs. Addressing
the burden of NTD-morbidity requires detailed information on the location of individuals
requiring CM, which is often lacking in maps of NTD distribution. It is intended that the
approach piloted here will be implemented in other countries where CM NTDs are
endemic, supporting the improvement of data on the distribution of NTD-related morbidity.
This would help inform investment in integrated CM and the integration of case detection
activities in Africa, promoting earlier, wider, and more equitable access to care for all those
affected by NTDs.
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Figure 1S. Frequency distribution of differences in case numbers recorded in leprosy district registers and district
totals reported to the Leprosy Elimination Program.
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Table 1S. Number of Buruli ulcer cases recorded in Ghana in 2014, by region, referral source, category of lesion and limitation of movement. WHO programmatic targets are
shown in brackets in column headings
Total
Detected by
CV or HW Category of lesion
% Cat III2
(#25%)
Limitation of movement
(LOM #15%)
% with LOM2
(#15%)
Ulcerative
n % I II III Unknown1 No Yes Unknown1 n % (#60%)
Ashanti 136 114 83·8 66 39 24 7 30·2 96 11 29 10·3 82 60·3
Brong Ahafo 32 11 34·4 10 9 8 5 33·3 28 4 0 12·5 30 93·8
Central 39 14 35·9 8 20 11 0 51·3 30 9 0 23·1 29 74·4
Eastern 62 36 58·1 27 12 23 0 19·4 44 18 0 29·0 57 91·9
Greater Accra 41 26 63·4 16 5 20 0 12·2 29 12 0 29·3 37 90·2
Western 23 2 8·7 0 7 16 0 30·4 20 3 0 13·0 16 69·6
Total 333 203 61·0 127 92 102 12 28·7 247 57 29 18·8 251 75·4
1Data not recorded. 2% of cases for whom this information was recorded.
CV ¼ community volunteer, HW ¼ health worker.
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Table 2S. Sensitivity analysis of the distribution of non-georeferenced cases on rates of disease by distance to health
facility
Reported leprosy
<5 km from
PHC
>5 km from
PHC
N. not geo
referenced
RR
Estimate2
RR
Lower3
RR
Upper4Area N Rate1 N Rate
All Regions 251 1·26 44 0·68 55 1·86 0·83 2·27
Greater Accra 28 0·68 0 0·00 0 – – –
Upper East 31 2·99 2 2·56 2 1·17 0·58 1·24
Ashanti 34 0·79 3 0·36 9 2·20 0·55 2·79
Central 6 0·34 2 0·33 1 1·03 0·68 1·20
Volta 46 2·73 3 0·52 2 5·24 3·15 5·47
Western 22 1·23 7 0·91 3 1·35 0·94 1·53
Eastern 24 1·23 0 0·00 7 – 1·56 –
Brong Ahafo 25 1·63 10 1·04 7 1·56 0·92 2·00
Upper West 23 5·28 7 2·25 7 2·35 1·17 3·06
Northern 12 0·89 10 0·77 17 1·15 0·43 2·77
Reported Buruli ulcer
< 5 km from
PHC
> 5 km from
PHC
N. not geo
referenced
RR
Estimate
RR
Lower
RR
UpperArea N Rate N Rate
All Regions 246 1·23 34 0·52 53 2·36 0·92 2·87
Greater Accra 30 0·73 1 0·52 10 1·42 0·13 1·89
Ashanti 94 2·19 17 2·03 25 1·07 0·44 1·36
Central 25 1·41 9 1·49 5 0·95 0·61 1·14
Western 12 0·67 3 0·39 8 1·71 0·47 2·86
Eastern 56 2·86 1 0·11 5 25·53 4·26 27·81
Brong Ahafo 29 1·89 3 0·31 0 6·03 6·03 6·03
Suspected filarial lymphedema
< 5 km from
PHC
> 5 km from
PHC
N. not geo
referenced
RR
Estimate
RR
Lower
RR
UpperArea N Rate N Rate
All Regions 1296 10·23 261 4·90 826 2·09 0·50 3·42
Greater Accra 25 0·86 0 0·00 8 – 0·16 –
Upper East 948 91·42 62 80·23 632 1·14 0·10 1·90
Ashanti 8 0·42 7 0·86 8 0·49 0·23 0·98
Central 103 7·61 20 3·25 31 2·34 0·92 3·05
Western 117 6·53 61 7·90 48 0·83 0·46 1·17
Eastern 43 3·06 19 2·30 25 1·33 0·57 2·10
Brong Ahafo 12 1·24 27 3·10 20 0·40 0·23 1·06
Northern 40 3·05 65 5·39 54 0·57 0·31 1·33
Rates of leprosy and BU were calculated from the number of newly reported cases in 2014 per 100,000 population;
rates of suspected lymphedema were calculated from the number of suspect cases recorded during morbidity
registration, per 100,000 population.
1RR ¼ Ratio of the rate within 5 km of PHC to that beyond 5 km of PHC.
2All non-georeferenced cases were assumed to occur ,5 km from the nearest PHC facility.
3All non-georeferenced cases were assumed to occur .5 km from the nearest PHC facility.
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Table 3S. Completeness of morbidity grading data among leprosy and Buruli ulcer (BU) cases by region
Reported leprosy cases
<5 km >5 km Total Mapped Total not georeferenced
Total
Graded
Total
Graded
Total
Graded
Total
Graded
N % (95% CIs) N % (95% CIs) N % (95% CIs) N % (95% CIs)
All Regions 251 208 82·9 (77·7–87) 44 27 61·4 (46·6–74·3) 295 235 79·7 (74·7–83·9) 55 29 52·7 (39·8–65·3)
Ashanti 34 34 100 (89·8–100) 3 3 100 (43·9–100) 37 37 100 (90·6–100) 9 9 100 (70·1–100)
Brong Ahafo 25 25 100 (86·7–100) 10 10 100 (72·2–100) 35 35 100 (90·1–100) 7 7 100 (64·6–100)
Central 6 6 100 (61–100) 2 2 100 (34·2–100) 8 8 100 (67·6–100) 1 1 100 (20·7–100)
Eastern 24 13 54·2 (35·1–72·1) 0 0 0 24 13 54·2 (35·1–72·1) 7 1 14·3 (2·6–51·3)
Greater Accra 28 28 100 (87·9–100) 0 0 0 28 28 100 (87·9–100) 0 0 0
Northern 12 2 16·7 (4·7–44·8) 10 0 0 (0–27·8) 22 2 9·1 (2·5–27·8) 17 0 0 (0–18·4)
Upper East 31 31 100 (89–100) 2 2 100 (34·2–100) 33 33 100 (89·6–100) 2 2 100 (34·2–100)
Upper West 23 23 100 (85·7–100) 7 7 100 (64·6–100) 30 30 100 (88·6–100) 7 7 100 (64·6–100)
Volta 46 46 100 (92·3–100) 3 3 100 (43·9–100) 49 49 100 (92·7–100) 2 2 100 (34·2–100)
Western 22 0 0 (0–14·9) 7 0 0 (0–35·4) 29 0 0 (0–11·7) 3 0 0 (0–56·1)
Reported BU cases
< 5 km > 5 km Total Mapped Total not georeferenced
Graded1 Graded1 Graded1 Graded1
Total N % (95% CIs) Total N % (95% CIs) Total N % (95% CIs) Total N % (95% CIs)
All Regions 246 216 87·8 (83·1–91·3) 34 29 85·3 (69·9–93·6) 280 245 87·5 (83·1–90·9) 53 50 94·3 (84·6–98·1)
Ashanti 94 69 73·4 (63·7–81·3) 17 12 70·6 (46·9–86·7) 111 81 73 (64–80·4) 25 22 88 (70–95·8)
Brong Ahafo 29 24 82·8 (65·5–92·4) 3 3 100 (43·9–100) 32 27 84·4 (68·2–93·1) 0 0 0
Central 25 25 100 (86·7–100) 9 9 100 (70·1–100) 34 34 100 (89·8–100) 5 5 100 (56·6–100)
Eastern 56 56 100 (93·6–100) 1 1 100 (20·7–100) 57 57 100 (93·7–100) 5 5 100 (56·6–100)
Greater Accra 30 30 100 (88·6–100) 1 1 100 (20·7–100) 31 31 100 (89–100) 10 10 100 (72·2–100)
Western 12 12 100 (75·8–100) 3 3 100 (43·9–100) 15 15 100 (79·6–100) 8 8 100 (67·6–100)
1Presence/absence of LOM and category of lesion recorded.
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